"daiichisankyo" - Google News

Daiichi Sankyo Expands Vanflyta Access As Oncology Data Shapes Growth Story - simplywall.st

Sun, 31 May 2026 02:23:29 GMT

Daiichi Sankyo Expands Vanflyta Access As Oncology Data Shapes Growth Story simplywall.st

Daiichi Sankyo takes $610M profit hit linked to ADC manufacturing overbuild - Fierce Pharma

Fri, 08 May 2026 07:00:00 GMT

Daiichi Sankyo takes $610M profit hit linked to ADC manufacturing overbuild Fierce Pharma

Daiichi Sankyo Showcases Progress Across Industry-Leading Oncology Portfolio with Latest Research Updates at ASCO - Business Wire

Thu, 28 May 2026 11:00:00 GMT

Daiichi Sankyo Showcases Progress Across Industry-Leading Oncology Portfolio with Latest Research Updates at ASCO Business Wire

AstraZeneca, Daiichi Sankyo’s Datroway receives FDA approval for TNBC - Pharmaceutical Technology

Mon, 25 May 2026 09:38:02 GMT

AstraZeneca, Daiichi Sankyo’s Datroway receives FDA approval for TNBC Pharmaceutical Technology

Daiichi Sankyo Europe Reaffirms Commitment to Patient-Centred Care with Extensive Data Showcase at EAS Congress 2026 - Yahoo Finance

Tue, 26 May 2026 15:00:00 GMT

Daiichi Sankyo Europe Reaffirms Commitment to Patient-Centred Care with Extensive Data Showcase at EAS Congress 2026 Yahoo Finance

Eyes on Asia: Fosun, Accro Biosciences, Daiichi Sankyo - BioXconomy

Tue, 26 May 2026 09:18:39 GMT

Eyes on Asia: Fosun, Accro Biosciences, Daiichi Sankyo BioXconomy

Daiichi Sankyo Unveils New Toronto Headquarters to Accelerate Investment and Innovation in Oncology - PR Newswire

Wed, 21 Jan 2026 08:00:00 GMT

Daiichi Sankyo Unveils New Toronto Headquarters to Accelerate Investment and Innovation in Oncology PR Newswire

Daiichi Sankyo Concludes pCPA Letter of Intent for Vanflyta® in Newly Diagnosed FLT3-ITD Positive AML - PR Newswire Canada

Thu, 28 May 2026 18:50:00 GMT

Daiichi Sankyo Concludes pCPA Letter of Intent for Vanflyta® in Newly Diagnosed FLT3-ITD Positive AML PR Newswire Canada

Daiichi Sankyo posts 'extraordinary loss' of nearly $1B after overestimating need for ADC capacity - Endpoints News

Fri, 08 May 2026 07:00:00 GMT

Daiichi Sankyo posts 'extraordinary loss' of nearly $1B after overestimating need for ADC capacity Endpoints News

Manufacturing hangover drives Daiichi Sankyo into the red - pharmaphorum

Fri, 08 May 2026 07:00:00 GMT

Manufacturing hangover drives Daiichi Sankyo into the red pharmaphorum

How Daiichi Sankyo modernized drug discovery using AWS Parallel Computing Service | Amazon Web Services - Amazon Web Services (AWS)

Wed, 19 Nov 2025 08:00:00 GMT

How Daiichi Sankyo modernized drug discovery using AWS Parallel Computing Service | Amazon Web Services Amazon Web Services (AWS)

HER2 in Gynecologic Cancers—Why It Matters - Daiichi Sankyo US

Tue, 03 Mar 2026 08:00:00 GMT

HER2 in Gynecologic Cancers—Why It Matters Daiichi Sankyo US

Daiichi Sankyo Concludes pCPA Letter Of Intent For Vanflyta® - TradingView

Thu, 28 May 2026 19:24:51 GMT

Daiichi Sankyo Concludes pCPA Letter Of Intent For Vanflyta® TradingView

Is It Time To Revisit Daiichi Sankyo (TSE:4568) After Its Recent Share Price Weakness? - simplywall.st

Fri, 29 May 2026 17:16:35 GMT

Is It Time To Revisit Daiichi Sankyo (TSE:4568) After Its Recent Share Price Weakness? simplywall.st

Daiichi Sankyo and Waiv partner for ADC biomarkers - Pharmaceutical Technology

Thu, 07 May 2026 07:00:00 GMT

Daiichi Sankyo and Waiv partner for ADC biomarkers Pharmaceutical Technology

Daiichi Sankyo Unveils New Five-Year Business Plan Focused on Oncology Leadership and Innovation - Yahoo Finance

Sun, 10 May 2026 07:00:00 GMT

Daiichi Sankyo Unveils New Five-Year Business Plan Focused on Oncology Leadership and Innovation Yahoo Finance

Daiichi pushes back annual report, citing reviews amid ‘rapidly changing business conditions’ - Fierce Pharma

Fri, 24 Apr 2026 07:00:00 GMT

Daiichi pushes back annual report, citing reviews amid ‘rapidly changing business conditions’ Fierce Pharma

The Bull Case For Daiichi Sankyo Company (TSE:4568) Could Change Following Its New Oncology-Focused 2030 Plan - Yahoo Finance

Mon, 11 May 2026 07:00:00 GMT

The Bull Case For Daiichi Sankyo Company (TSE:4568) Could Change Following Its New Oncology-Focused 2030 Plan Yahoo Finance

In industry's latest OTC pivot, Daiichi Sankyo lines up $1.5B consumer health unit sale to beverage giant Suntory - Fierce Pharma

Wed, 15 Apr 2026 07:00:00 GMT

In industry's latest OTC pivot, Daiichi Sankyo lines up $1.5B consumer health unit sale to beverage giant Suntory Fierce Pharma

Daiichi Sankyo targets global top 5 oncology rank by 2035, $1.3B efficiency drive in new 5-year plan - Fierce Pharma

Mon, 11 May 2026 07:00:00 GMT

Daiichi Sankyo targets global top 5 oncology rank by 2035, $1.3B efficiency drive in new 5-year plan Fierce Pharma

Daiichi Sankyo navigates complexity of success as Enhertu, Datroway push for market dominance - Fierce Pharma

Mon, 26 Jan 2026 08:00:00 GMT

Daiichi Sankyo navigates complexity of success as Enhertu, Datroway push for market dominance Fierce Pharma

Daiichi Sankyo's Antibody-Drug Conjugate Platform Shines but Faces Increasing Competition - Morningstar

Wed, 13 May 2026 07:00:00 GMT

Daiichi Sankyo's Antibody-Drug Conjugate Platform Shines but Faces Increasing Competition Morningstar

Daiichi Sankyo and Tempus AI collaborate on ADC clinical development - Pharmaceutical Technology

Thu, 26 Mar 2026 07:00:00 GMT

Daiichi Sankyo and Tempus AI collaborate on ADC clinical development Pharmaceutical Technology

FDA grants Daiichi Sankyo and AstraZeneca’s Datroway a key breast cancer approval - Endpoints News

Fri, 22 May 2026 15:28:00 GMT

FDA grants Daiichi Sankyo and AstraZeneca’s Datroway a key breast cancer approval Endpoints News

Daiichi's ADC miscalculation leads to compensation of over $480M to CMOs - FirstWord Pharma

Fri, 08 May 2026 07:00:00 GMT

Daiichi's ADC miscalculation leads to compensation of over $480M to CMOs FirstWord Pharma

GAIA and Daiichi Sankyo Europe Enter Exclusive Partnership to Launch Next-Generation Digital Therapeutic for Cardiovascular Care in Europe. - Business Wire

Thu, 05 Mar 2026 08:00:00 GMT

GAIA and Daiichi Sankyo Europe Enter Exclusive Partnership to Launch Next-Generation Digital Therapeutic for Cardiovascular Care in Europe. Business Wire

FDA Action Alert: Argenx, AstraZeneca/Daiichi Sankyo, Biogen/Eisai and Cingulate - BioSpace

Mon, 04 May 2026 07:00:00 GMT

FDA Action Alert: Argenx, AstraZeneca/Daiichi Sankyo, Biogen/Eisai and Cingulate BioSpace

Daiichi Sankyo Presents New Clinical Research And Product Pipeline Updates Across Oncology Portfolio At ASCO - marketscreener.com

Thu, 28 May 2026 12:07:08 GMT

Daiichi Sankyo Presents New Clinical Research And Product Pipeline Updates Across Oncology Portfolio At ASCO marketscreener.com

Daiichi Sankyo Appoints John Tsai, MD as Global Head of R&D - Business Wire

Thu, 19 Feb 2026 08:00:00 GMT

Daiichi Sankyo Appoints John Tsai, MD as Global Head of R&D Business Wire

Daiichi Sankyo unveils new five-year business plan - The Pharma Letter

Mon, 11 May 2026 14:19:12 GMT

Daiichi Sankyo unveils new five-year business plan The Pharma Letter

Daiichi Sankyo Taps Imagene AI for Biomarker Discovery - BioPharm International

Fri, 10 Apr 2026 07:00:00 GMT

Daiichi Sankyo Taps Imagene AI for Biomarker Discovery BioPharm International

Is It Time To Reconsider Daiichi Sankyo Company (TSE:4568) After Recent Share Price Weakness? - Yahoo Finance

Tue, 13 Jan 2026 08:00:00 GMT

Is It Time To Reconsider Daiichi Sankyo Company (TSE:4568) After Recent Share Price Weakness? Yahoo Finance

FDA Priority Review And New Alliances Reshape Daiichi Sankyo Growth Story - Yahoo Finance

Mon, 13 Apr 2026 07:00:00 GMT

FDA Priority Review And New Alliances Reshape Daiichi Sankyo Growth Story Yahoo Finance

Daiichi Sankyo Bets on New Cancer Drugs to Fuel Future Growth - Bloomberg.com

Mon, 11 May 2026 07:00:00 GMT

Daiichi Sankyo Bets on New Cancer Drugs to Fuel Future Growth Bloomberg.com

Culture-Driven Talent Acquisition: How Daiichi Sankyo Builds Teams - Daiichi Sankyo US

Thu, 28 Aug 2025 07:00:00 GMT

Culture-Driven Talent Acquisition: How Daiichi Sankyo Builds Teams Daiichi Sankyo US

Leveragen Announces Collaboration with Daiichi Sankyo to Support Development of Advanced Biologics Using Next-Gen In Vivo Antibody Discovery Platforms - Business Wire

Wed, 18 Mar 2026 07:00:00 GMT

Leveragen Announces Collaboration with Daiichi Sankyo to Support Development of Advanced Biologics Using Next-Gen In Vivo Antibody Discovery Platforms Business Wire

Daiichi Sankyo shares slip after delaying annual earnings report - BioSpace

Fri, 24 Apr 2026 07:00:00 GMT

Daiichi Sankyo shares slip after delaying annual earnings report BioSpace

Daiichi Sankyo Deepens Biologics Push As ENHERTU Faces FDA Decision - Yahoo Finance

Wed, 18 Mar 2026 07:00:00 GMT

Daiichi Sankyo Deepens Biologics Push As ENHERTU Faces FDA Decision Yahoo Finance

Daiichi Sankyo and Interna partner for MNM-targeted delivery solutions - Pharmaceutical Technology

Fri, 17 Apr 2026 07:00:00 GMT

Daiichi Sankyo and Interna partner for MNM-targeted delivery solutions Pharmaceutical Technology

Waiv Enters Collaboration with Daiichi Sankyo to Deliver AI-Derived Biomarkers for ADC Program - Business Wire

Wed, 06 May 2026 07:00:00 GMT

Waiv Enters Collaboration with Daiichi Sankyo to Deliver AI-Derived Biomarkers for ADC Program Business Wire

Tempus AI Daiichi Sankyo Tie Up Highlights Precision Oncology Opportunity - Yahoo Finance

Tue, 31 Mar 2026 07:00:00 GMT

Tempus AI Daiichi Sankyo Tie Up Highlights Precision Oncology Opportunity Yahoo Finance

ATLATL Announces Agreement with Daiichi Sankyo to Deepen APAC Biotech Innovation - Yahoo Finance

Tue, 07 Apr 2026 07:00:00 GMT

ATLATL Announces Agreement with Daiichi Sankyo to Deepen APAC Biotech Innovation Yahoo Finance

Voro Therapeutics Announces Research Collaboration with Daiichi Sankyo to Advance PrimeBody™ Technology for Next-Generation Tumor-Activated ADCs - Business Wire

Tue, 17 Mar 2026 07:00:00 GMT

Voro Therapeutics Announces Research Collaboration with Daiichi Sankyo to Advance PrimeBody™ Technology for Next-Generation Tumor-Activated ADCs Business Wire

Daiichi Sankyo’s ADC Alliances Test Valuation Gap In Oncology Strategy - Yahoo Finance

Sat, 28 Mar 2026 07:00:00 GMT

Daiichi Sankyo’s ADC Alliances Test Valuation Gap In Oncology Strategy Yahoo Finance

Daiichi Sankyo Dumps Next-Gen ADC From Development Pipeline - BioSpace

Tue, 03 Feb 2026 08:00:00 GMT

Daiichi Sankyo Dumps Next-Gen ADC From Development Pipeline BioSpace

A Look At Daiichi Sankyo Company (TSE:4568) Valuation As Oncology Pipeline Drives Undervalued Thesis - Yahoo Finance

Fri, 01 May 2026 07:00:00 GMT

A Look At Daiichi Sankyo Company (TSE:4568) Valuation As Oncology Pipeline Drives Undervalued Thesis Yahoo Finance

Daiichi Sankyo Appoints New Leadership at the Daiichi Sankyo Translational Research Center Europe - Business Wire

Thu, 22 Jan 2026 08:00:00 GMT

Daiichi Sankyo Appoints New Leadership at the Daiichi Sankyo Translational Research Center Europe Business Wire

Daiichi Sankyo Partnering With ATLATL Innovation Center to Accelerate APAC Biotech Innovation - Contract Pharma

Wed, 08 Apr 2026 07:00:00 GMT

Daiichi Sankyo Partnering With ATLATL Innovation Center to Accelerate APAC Biotech Innovation Contract Pharma

Daiichi Sankyo Company, Limited (DSNKY) 2026 Guidance/Update Call - Slideshow - Seeking Alpha

Thu, 14 May 2026 07:00:00 GMT

Daiichi Sankyo Company, Limited (DSNKY) 2026 Guidance/Update Call - Slideshow Seeking Alpha

Interna Therapeutics Announces Research Collaboration with Daiichi Sankyo to Advance MNM-Based Targeted Delivery Technologies - Yahoo Finance

Thu, 16 Apr 2026 07:00:00 GMT

Interna Therapeutics Announces Research Collaboration with Daiichi Sankyo to Advance MNM-Based Targeted Delivery Technologies Yahoo Finance

Suntory Buying Daiichi Sankyo Unit for $1.3 Billion, Nikkei Says - Bloomberg.com

Wed, 15 Apr 2026 07:00:00 GMT

Suntory Buying Daiichi Sankyo Unit for $1.3 Billion, Nikkei Says Bloomberg.com

Daiichi Sankyo Establishes Third Research Institute in San Diego - Business Wire

Thu, 02 Oct 2025 07:00:00 GMT

Daiichi Sankyo Establishes Third Research Institute in San Diego Business Wire

Lunit and Daiichi Sankyo Form Collaboration to Advance Research and Discovery for AI-Driven Biomarkers and Translational Oncology - PharmExec.com

Tue, 16 Dec 2025 08:00:00 GMT

Lunit and Daiichi Sankyo Form Collaboration to Advance Research and Discovery for AI-Driven Biomarkers and Translational Oncology PharmExec.com

Assessing Daiichi Sankyo (TSE:4568) Valuation After A Year Of Weak Share Price Returns - Yahoo Finance

Mon, 13 Apr 2026 07:00:00 GMT

Assessing Daiichi Sankyo (TSE:4568) Valuation After A Year Of Weak Share Price Returns Yahoo Finance

Breast Cancer Treatment From Daiichi Sankyo, AstraZeneca Approved in U.S. - Moomoo

Fri, 15 May 2026 22:45:00 GMT

Breast Cancer Treatment From Daiichi Sankyo, AstraZeneca Approved in U.S. Moomoo

Daiichi Sankyo prevails on appeal in long-running ADC patent battle with Seagen, flipping prior $41.8M verdict - Fierce Pharma

Wed, 03 Dec 2025 08:00:00 GMT

Daiichi Sankyo prevails on appeal in long-running ADC patent battle with Seagen, flipping prior $41.8M verdict Fierce Pharma

Is Daiichi Sankyo (TSE:4568) Turning ENHERTU’s China Approval Into a Durable Oncology Moat? - Yahoo Finance

Fri, 23 Jan 2026 08:00:00 GMT

Is Daiichi Sankyo (TSE:4568) Turning ENHERTU’s China Approval Into a Durable Oncology Moat? Yahoo Finance

A Look At Daiichi Sankyo (TSE:4568) Valuation After ENHERTU’s Expanded US FDA Approvals - simplywall.st

Fri, 22 May 2026 07:21:11 GMT

A Look At Daiichi Sankyo (TSE:4568) Valuation After ENHERTU’s Expanded US FDA Approvals simplywall.st

Daiichi Sankyo tallies $1.9B in planned Enhertu manufacturing investments: Nikkei - Fierce Pharma

Mon, 05 Jan 2026 08:00:00 GMT

Daiichi Sankyo tallies $1.9B in planned Enhertu manufacturing investments: Nikkei Fierce Pharma

Daiichi Sankyo gears up for five ADC launches in 2026 - pharmaphorum

Mon, 23 Feb 2026 08:00:00 GMT

Daiichi Sankyo gears up for five ADC launches in 2026 pharmaphorum

MSD, Daiichi Sankyo’s ifinatamab deruxtecan receives FDA priority - Pharmaceutical Technology

Tue, 14 Apr 2026 07:00:00 GMT

MSD, Daiichi Sankyo’s ifinatamab deruxtecan receives FDA priority Pharmaceutical Technology

Japan's Daiichi Sankyo unveils five-year business plan focused on oncology innovation - BioSpectrum Asia

Mon, 11 May 2026 07:23:54 GMT

Japan's Daiichi Sankyo unveils five-year business plan focused on oncology innovation BioSpectrum Asia

Daiichi Sankyo Leverages AI to Strengthen ADC Clinical Strategy - BioPharm International

Thu, 26 Mar 2026 07:00:00 GMT

Daiichi Sankyo Leverages AI to Strengthen ADC Clinical Strategy BioPharm International

Is Daiichi Sankyo (TSE:4568) Undervalued After Recent Share Price Weakness? A Fresh Look at Its 2028 Outlook - Yahoo Finance

Wed, 17 Dec 2025 08:00:00 GMT

Is Daiichi Sankyo (TSE:4568) Undervalued After Recent Share Price Weakness? A Fresh Look at Its 2028 Outlook Yahoo Finance

BostonGene Announces Strategic Collaboration with Daiichi Sankyo to Accelerate Drug Development Through AI-Driven Multimodal Analytics - Yahoo Finance

Tue, 17 Feb 2026 08:00:00 GMT

BostonGene Announces Strategic Collaboration with Daiichi Sankyo to Accelerate Drug Development Through AI-Driven Multimodal Analytics Yahoo Finance

Is Daiichi Sankyo Now an Opportunity After a 26% Share Price Slide? - Yahoo Finance

Wed, 03 Dec 2025 08:00:00 GMT

Is Daiichi Sankyo Now an Opportunity After a 26% Share Price Slide? Yahoo Finance

What is Daiichi Sankyo’s Post JP Morgan Strategy? - PharmExec.com

Thu, 22 Jan 2026 08:00:00 GMT

What is Daiichi Sankyo’s Post JP Morgan Strategy? PharmExec.com

Daiichi Sankyo Shares Fall After Delaying Earnings Results - Bloomberg.com

Thu, 23 Apr 2026 07:00:00 GMT

Daiichi Sankyo Shares Fall After Delaying Earnings Results Bloomberg.com

Suntory to buy Daiichi Sankyo OTC unit for $1.2 bln - Nikkei - Investing.com

Wed, 15 Apr 2026 07:00:00 GMT

Suntory to buy Daiichi Sankyo OTC unit for $1.2 bln - Nikkei Investing.com

Merck, Daiichi Sankyo Stage Lung Cancer Rally With ‘Strong’ Pivotal Data for I-Dxd - BioSpace

Mon, 08 Sep 2025 07:00:00 GMT

Merck, Daiichi Sankyo Stage Lung Cancer Rally With ‘Strong’ Pivotal Data for I-Dxd BioSpace

What is Daiichi Sankyo’s Strategy for Preparing for the JP Morgan Healthcare Conference? - PharmExec.com

Fri, 16 Jan 2026 08:00:00 GMT

What is Daiichi Sankyo’s Strategy for Preparing for the JP Morgan Healthcare Conference? PharmExec.com

Daiichi Sankyo – Cleanroom fit-out for the fill & finish area - Cleanroom Technology

Fri, 08 May 2026 11:30:24 GMT

Daiichi Sankyo – Cleanroom fit-out for the fill & finish area Cleanroom Technology

SylamoreBio Announces Research Collaboration With Daiichi Sankyo to Advance SyLEC™ Delivery Technology - BioSpace

Mon, 23 Feb 2026 08:00:00 GMT

SylamoreBio Announces Research Collaboration With Daiichi Sankyo to Advance SyLEC™ Delivery Technology BioSpace

AstraZeneca, Daiichi Sankyo's Enhertu Recommended for EU Approval for HER2-Positive Solid Tumors - Moomoo

Fri, 22 May 2026 13:45:15 GMT

AstraZeneca, Daiichi Sankyo's Enhertu Recommended for EU Approval for HER2-Positive Solid Tumors Moomoo

Daiichi Sankyo Company, Limited Just Missed EPS By 12%: Here's What Analysts Think Will Happen Next - simplywall.st

Wed, 13 May 2026 07:00:00 GMT

Daiichi Sankyo Company, Limited Just Missed EPS By 12%: Here's What Analysts Think Will Happen Next simplywall.st

General Proximity Announces Multi-Target Collaboration with Daiichi Sankyo to Discover and Advance Novel Oncology Therapeutics Using OmniTAC™ Platform - PR Newswire

Thu, 13 Nov 2025 08:00:00 GMT

General Proximity Announces Multi-Target Collaboration with Daiichi Sankyo to Discover and Advance Novel Oncology Therapeutics Using OmniTAC™ Platform PR Newswire

Daiichi Sankyo turns to Tempus AI to boost ADC development - FirstWord Pharma

Wed, 25 Mar 2026 07:00:00 GMT

Daiichi Sankyo turns to Tempus AI to boost ADC development FirstWord Pharma

Lunit Announces Collaboration with Daiichi Sankyo to Advance AI-Driven Biomarker Discovery and Translational Oncology Research - PR Newswire

Mon, 15 Dec 2025 08:00:00 GMT

Lunit Announces Collaboration with Daiichi Sankyo to Advance AI-Driven Biomarker Discovery and Translational Oncology Research PR Newswire

Daiichi Sankyo and GENESIS Pharma Enter Exclusive Agreement for VANFLYTA - Business Wire

Wed, 07 Jan 2026 08:00:00 GMT

Daiichi Sankyo and GENESIS Pharma Enter Exclusive Agreement for VANFLYTA Business Wire

Eyes on Asia: Takeda, Daiichi Sankyo, Biogen - BioXconomy

Tue, 28 Apr 2026 07:00:00 GMT

Eyes on Asia: Takeda, Daiichi Sankyo, Biogen BioXconomy

DS3790 Enters Clinical Development as First DXd ADC in Hematology from Industry-Leading ADC Portfolio of Daiichi Sankyo - Business Wire

Wed, 04 Feb 2026 08:00:00 GMT

DS3790 Enters Clinical Development as First DXd ADC in Hematology from Industry-Leading ADC Portfolio of Daiichi Sankyo Business Wire

AstraZeneca, Daiichi Sankyo Move Enhertu to First-Line Metastatic Breast Cancer - BioSpace

Tue, 16 Dec 2025 08:00:00 GMT

AstraZeneca, Daiichi Sankyo Move Enhertu to First-Line Metastatic Breast Cancer BioSpace

Daiichi Sankyo taps ATLATL network to deepen innovation - The Pharma Letter

Thu, 09 Apr 2026 07:00:00 GMT

Daiichi Sankyo taps ATLATL network to deepen innovation The Pharma Letter

Daiichi Sankyo picks Dr John Tsai to head up R&D - European Pharmaceutical Review

Fri, 20 Feb 2026 08:00:00 GMT

Daiichi Sankyo picks Dr John Tsai to head up R&D European Pharmaceutical Review

Is It Time To Revisit Daiichi Sankyo (TSE:4568) After This Year’s 26% Share Price Slide? - simplywall.st

Fri, 08 May 2026 07:00:00 GMT

Is It Time To Revisit Daiichi Sankyo (TSE:4568) After This Year’s 26% Share Price Slide? simplywall.st

AstraZeneca, Daiichi Sankyo Win US FDA Approval for Datroway to Treat Triple-Negative Breast Cancer - Moomoo

Fri, 22 May 2026 14:32:48 GMT

AstraZeneca, Daiichi Sankyo Win US FDA Approval for Datroway to Treat Triple-Negative Breast Cancer Moomoo

Daiichi wins appeal of $42 million US verdict in Enhertu patent case - Reuters

Tue, 02 Dec 2025 08:00:00 GMT

Daiichi wins appeal of $42 million US verdict in Enhertu patent case Reuters

Wayfinder Biosciences Advances Collaboration with Daiichi Sankyo on Key Neurodegeneration Target to Second Phase - PR Newswire

Wed, 15 Apr 2026 07:00:00 GMT

Wayfinder Biosciences Advances Collaboration with Daiichi Sankyo on Key Neurodegeneration Target to Second Phase PR Newswire

Nuvation Bio Announces Acquisition of Japan Rights to Safusidenib from Daiichi Sankyo - PR Newswire

Wed, 01 Apr 2026 07:00:00 GMT

Nuvation Bio Announces Acquisition of Japan Rights to Safusidenib from Daiichi Sankyo PR Newswire

Daiichi Sankyo Waiv Alliance Ties AI Pathology To ADC Valuation Story - simplywall.st

Sat, 09 May 2026 07:00:00 GMT

Daiichi Sankyo Waiv Alliance Ties AI Pathology To ADC Valuation Story simplywall.st

Lunit, Daiichi Sankyo collaborate on AI pathology in oncology research - FirstWord Pharma

Tue, 16 Dec 2025 08:00:00 GMT

Lunit, Daiichi Sankyo collaborate on AI pathology in oncology research FirstWord Pharma

Daiichi Sankyo pens pact with Germany's Gaia to sell digital therapeutic for high cholesterol - Fierce Biotech

Thu, 05 Mar 2026 08:00:00 GMT

Daiichi Sankyo pens pact with Germany's Gaia to sell digital therapeutic for high cholesterol Fierce Biotech

Is Now The Right Time To Reassess Daiichi Sankyo (TSE:4568) After Recent Share Price Weakness? - Yahoo Finance

Wed, 18 Mar 2026 07:00:00 GMT

Is Now The Right Time To Reassess Daiichi Sankyo (TSE:4568) After Recent Share Price Weakness? Yahoo Finance

Daiichi Sankyo 4Q Global Revenue From Enhertu Y284.1B Vs Y229.9B a Year Earlier - Moomoo

Sun, 10 May 2026 07:00:00 GMT

Daiichi Sankyo 4Q Global Revenue From Enhertu Y284.1B Vs Y229.9B a Year Earlier Moomoo

Daiichi Sankyo 4Q Net Profit Missed Y85.5B Expected in Poll of Analysts by Visible Alpha - Moomoo

Sun, 10 May 2026 07:00:00 GMT

Daiichi Sankyo 4Q Net Profit Missed Y85.5B Expected in Poll of Analysts by Visible Alpha Moomoo

Revenue of Daiichi Sankyo Company, Limited from 2020 to 2024 - Statista

Thu, 19 Mar 2026 07:00:00 GMT

Revenue of Daiichi Sankyo Company, Limited from 2020 to 2024 Statista

Daiichi Sankyo postpones annual results, stock dips - Endpoints News

Fri, 24 Apr 2026 07:00:00 GMT

Daiichi Sankyo postpones annual results, stock dips Endpoints News

New Indication Alert: BMS/Daiichi Sankyo’s Enhertu® (Trastuzumab Deruxtecan) Approved for HER2-Positive Early-Stage Breast Cancer in US - Pearce IP

Fri, 15 May 2026 07:00:00 GMT

New Indication Alert: BMS/Daiichi Sankyo’s Enhertu® (Trastuzumab Deruxtecan) Approved for HER2-Positive Early-Stage Breast Cancer in US Pearce IP

Stock Pitch: Daiichi Sankyo (TSE: 4568) - Morningstar

Tue, 21 Oct 2025 07:00:00 GMT

Stock Pitch: Daiichi Sankyo (TSE: 4568) Morningstar

AstraZeneca–Daiichi Sankyo’s ADC, Enhertu, Gets FDA Priority Review in Early Breast Cancer - BioPharm International

Mon, 09 Mar 2026 07:00:00 GMT

AstraZeneca–Daiichi Sankyo’s ADC, Enhertu, Gets FDA Priority Review in Early Breast Cancer BioPharm International